| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin
|
Schrump, D.S.
|
|
2007
|
8 |
7 |
p. 453-
1 p.
|
artikel
|
| 2 |
Clinical Development of Vandetanib: A Review of Ongoing Phase III Clinical Trials in Advanced NSCLC
|
Heymach, J.
|
|
2007
|
8 |
7 |
p. 446-
1 p.
|
artikel
|
| 3 |
Dedifferentiated Chondrosarcoma of the Lung: Case Report and Review of the Literature
|
Steurer, Stefan
|
|
2007
|
8 |
7 |
p. 439-442
4 p.
|
artikel
|
| 4 |
Dual Inhibition: Combining Epidermal Growth Factor–Targeted Therapies in Non–Small-Cell Lung Cancer
|
Ho, Cheryl
|
|
2007
|
8 |
7 |
p. 420-424
5 p.
|
artikel
|
| 5 |
Early Prediction of Response to Anticancer Therapy in Patients with Advanced/Metastatic Non–Small-Cell Lung Cancer Using FDG-PET-CT
|
Lee, D.H.
|
|
2007
|
8 |
7 |
p. 449-
1 p.
|
artikel
|
| 6 |
Efficacy and Safety of Single-Agent Axitinib (AG-013736; AG) in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC): A Phase II Trial
|
Schiller, J.H.
|
|
2007
|
8 |
7 |
p. 452-
1 p.
|
artikel
|
| 7 |
ErbB4 Expression and Mutation in Japanese Patients with Lung Cancer
|
Sasaki, Hidefumi
|
|
2007
|
8 |
7 |
p. 429-433
5 p.
|
artikel
|
| 8 |
Erlotinib as a Single Agent in Select Subsets of Patients with Advanced Non–Small-Cell Lung Cancer
|
Carrión, Ramón Pérez
|
|
2007
|
8 |
7 |
p. 425-428
4 p.
|
artikel
|
| 9 |
Erlotinib Monotherapy for Stage IIIB/IV Non–Small-Cell Lung Cancer in Korea; Expanded Access Program for Patients Failing Previous Treatment(s)
|
Park, B.-B.
|
|
2007
|
8 |
7 |
p. 443-
1 p.
|
artikel
|
| 10 |
Evaluation of the Use of Prophylactic Cranial Irradiation in Small-Cell Lung Cancer
|
Patel, S.
|
|
2007
|
8 |
7 |
p. 450-
1 p.
|
artikel
|
| 11 |
Frontline Cytotoxic Chemotherapy (CTx) for Newly Diagnosed Non–Small-Cell Lung Cancer (NSCLC) Patients Presenting with Brain Metastasis Compared to Whole-Brain Radiotherapy (WBRT): Result of a Randomized Pilot Study
|
Lee, D.H.
|
|
2007
|
8 |
7 |
p. 448-
1 p.
|
artikel
|
| 12 |
Malignancy-Related Hypercalcemia Developing on a Bisphosphonate but Responding to Calcitonin
|
Diskin, Charles J.
|
|
2007
|
8 |
7 |
p. 434-435
2 p.
|
artikel
|
| 13 |
Metastatic Brain Mass Caused by Slow-Growing Small-Cell Lung Cancer: Differential Vascular Endothelial Growth Factor Expression in Primary and Metastatic Tumor
|
Inoue, Satoshi
|
|
2007
|
8 |
7 |
p. 436-438
3 p.
|
artikel
|
| 14 |
Motexafin Gadolinium (MGd) is Active as a Single Agent and in Combination with Pemetrexed and Docetaxel in Advanced Non–Small-Cell Lung Cancer (NSCLC) Patients who Failed Platinum-Based Chemotherapy: Early Results of 3 Phase II Trials
|
Natale, R.B.
|
|
2007
|
8 |
7 |
p. 455-
1 p.
|
artikel
|
| 15 |
Phase II Study of Continuous Daily Sunitinib Dosing in Patients with Previously Treated Advanced Non–Small-Cell Lung Cancer (NSCLC)
|
Scagliotti, G.V.
|
|
2007
|
8 |
7 |
p. 451-
1 p.
|
artikel
|
| 16 |
Phase II Trial of Bevacizumab plus Pemetrexed and Carboplatin in Previously Untreated Advanced Nonsquamous Non–Small-Cell Lung Cancer
|
Dalsania, C.
|
|
2007
|
8 |
7 |
p. 444-
1 p.
|
artikel
|
| 17 |
Review of Pulmonary Hemorrhage (PH) in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Bevacizumab and Cisplatin plus Gemcitabine on Protocol BO17704
|
LaFleur, F.
|
|
2007
|
8 |
7 |
p. 447-
1 p.
|
artikel
|
| 18 |
Safety of Bevacizumab Therapy in Subjects with Brain Metastases due to Non–Small-Cell Lung Cancer (NSCLC)
|
Hainsworth, J.
|
|
2007
|
8 |
7 |
p. 445-
1 p.
|
artikel
|
| 19 |
Safety of Bevacizumab Treatment in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Full-Dose Anticoagulation (FDAC) Treated on Protocol BO17704
|
Skillings, J.
|
|
2007
|
8 |
7 |
p. 454-
1 p.
|
artikel
|
| 20 |
Selected Clinical Trials in Lung Cancer
|
Langer, Corey J.
|
|
2007
|
8 |
7 |
p. 456-
1 p.
|
artikel
|
| 21 |
The Potential of Death Receptor 4– and 5–Directed Therapies in the Treatment of Lung Cancer
|
Camidge, D. Ross
|
|
2007
|
8 |
7 |
p. 413-419
7 p.
|
artikel
|
Tijdschrift beschrijving